Typical AOD-9604 dosage per day for weight loss runs 250–500 mcg injected, but no human trial proves it works. Learn the evidence, risks and legal status.
AOD-9604 is commonly dosed at 250–500 mcg per day by subcutaneous injection, but no human trial has shown that any daily amount produces meaningful weight loss. AOD-9604 is not FDA-approved for weight loss or any other human use in the United States, and the largest clinical study of the peptide failed to meet its weight-loss goal.
What Is a Typical AOD-9604 Dosage Per Day?
Almost every protocol circulating online lands in the same narrow band. The most cited figure is 300 mcg once daily, injected under the skin in the morning on an empty stomach, for roughly 8 to 12 weeks.
| Protocol level | Daily dose | Frequency | Notes |
|---|---|---|---|
| Low / beginner | 250 mcg | Once daily | Lowest amount most protocols list |
| Standard | 300 mcg | Once daily | Most frequently repeated number |
| Higher | 500 mcg | Once, or split into 2 × 250 mcg | Upper end of the commonly cited range |
| Cycle length | — | 8–12 weeks | Community convention, not clinical guidance |
Because AOD-9604 clears from the body quickly, some users split the same total into two smaller injections. No human pharmacokinetic study shows that split dosing is superior, and no research establishes an ideal dose. That gap is one reason interest in the dosage for aod 9604 stays high even though the clinical record is thin.
Oral vs. Injectable AOD-9604
Both oral and injectable versions are sold online, and they are not interchangeable. AOD-9604 is a peptide, and stomach acid and digestive enzymes break peptides down when they are swallowed, so oral absorption is low and unpredictable.
Injectable forms bypass digestion, but they carry injection-site risks and sterility concerns. These products are sold as research chemicals rather than approved medicines, which means purity and dose accuracy are not guaranteed.
Does the Daily Dose Differ for Men and Women?
No. There is no evidence that sex changes the dose, and the numbers people describe as an aod 9604 dosage for men and an aod 9604 dosage for women are effectively the same 250–500 mcg range.
Body size matters more than sex in theory, since exposure to any drug scales with body weight. Even so, the AOD-9604 human trials did not identify a weight-based dosing strategy, and no study has compared outcomes in men versus women at different doses.
What the Human Research Actually Shows
In 2007, Metabolic Pharmaceuticals ran a Phase IIb trial of AOD-9604 in roughly 500 adults with obesity. The study did not reach its primary endpoint: participants taking AOD-9604 did not lose significantly more weight than those taking a placebo.
Earlier laboratory work did show real biological activity. AOD-9604 is a modified fragment of human growth hormone (amino acids 176–191) that stimulates lipolysis and inhibits lipogenesis in fat cells.
Fat-cell and animal findings do not prove that a peptide helps people lose weight, and the largest human trial of AOD-9604 failed to show a meaningful effect.
Why There Is No Official AOD-9604 Dose
No health agency publishes a recommended AOD-9604 dose because the peptide has never been approved as a drug. There is no package insert, no prescribing label, and no medical society guideline to reference.
That vacuum is filled by forum posts, vendor blogs, and recycled PDFs. As a result, the “standard” 300 mcg figure is a convention repeated often enough to sound authoritative, not a finding from controlled research.
Beginner Dosing and Practical Precautions
Newcomers often search for an aod 9604 peptide dosage for beginners, and most of those write-ups simply start at the bottom of the same range — 250 mcg per day. That is a convention, not a clinically validated starting dose.
Anyone weighing an aod 9604 peptide for weight loss should understand the practical realities before considering a first injection:
- Research chemicals are not quality-controlled the way prescription drugs are, so the label may not match the vial.
- Reconstituted peptides usually need refrigeration and careful handling to stay stable.
- Injections carry risks of infection, bruising, and skin reactions even with good technique.
- Blood work and medical supervision are the only reliable way to catch problems early.
Safety, Side Effects, and Legal Status
AOD-9604 is not FDA-approved for any human use, and it is banned by the World Anti-Doping Agency. In trials, reported side effects were mostly mild: injection-site reactions, headache, and occasional digestive upset.
Long-term safety data in humans do not exist. Anyone who is pregnant, breastfeeding, living with cancer, or taking prescription medication should speak with a healthcare professional before using this peptide.
Typical protocols suggest a cycle of 8 to 12 weeks, but that timeline comes from community habit rather than trial data. No study defines when results should appear, or whether they persist after stopping.
How AOD-9604 Compares With Proven Weight-Loss Options
| Option | Human evidence | Typical weight loss | FDA status |
|---|---|---|---|
| AOD-9604 | One large Phase IIb trial; primary endpoint not met | Not established | Not approved |
| Semaglutide (Wegovy) | Multiple large randomized trials | About 15% of body weight | Approved for weight loss |
| Tirzepatide (Zepbound) | Multiple large randomized trials | About 20% of body weight | Approved for weight loss |
| Diet, exercise, behavior change | Decades of research | About 5–10% | Not applicable |
AOD-9604 does not have the human evidence to compete with FDA-approved medications, and it is not sold legally for human use. That gap between marketing and data is the most important thing to understand about this peptide.
Frequently Asked Questions
How much AOD-9604 should I take per day for weight loss?
Online protocols typically list 250–500 mcg per day injected subcutaneously, with 300 mcg once daily as the most repeated figure. No human trial has proven that any dose causes meaningful weight loss, and there is no FDA-approved recommended dose. Anyone considering it should talk with a healthcare professional first.
Does AOD-9604 actually work for weight loss?
The largest human trial, a 2007 Phase IIb study in about 500 adults with obesity, did not show statistically significant weight loss compared with placebo. Laboratory studies do show effects on fat cells, but those findings have not translated into results in people. AOD-9604 is not FDA-approved for weight loss.
Is AOD-9604 safe to buy online?
Products sold online are labeled for research use only, so purity, sterility, and actual dose are not guaranteed. Reported short-term side effects in trials were mostly mild, including injection-site reactions and headaches, but long-term safety data in humans do not exist. AOD-9604 is also banned by the World Anti-Doping Agency.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.